Welcome
Dear Esteemed Colleagues and Friends:
Malignant tumors are major diseases that endanger human health and life. Tumor development and development is a multi-factor-induced complex process. Exploring its mechanism is the key to effective prevention and treatment, and it has always been the focus and difficulty of medical research. In recent years, as new technologies and methods in areas such as tumor metabolism, tumor immunity, and tumor markers continue to innovate, new products continue to emerge, the concept of cancer research and treatment continues to change, and cancer diagnosis and treatment has made significant progress. In order to further promote cancer research technology and method innovation and promote the transformation of basic research into clinical and industrial transformation, the First International Cancer Conference & the Third International Conference for Cancer Metabolism and Treatment& the Fourth National Conference on Cancer Metabolism will be held on October 12th to 14th , 2018 in Shanghai.
The conference gathered with big names, Academicians Guoqiang Chen, Academician Dongxin Lin, Academician Hongyang Wang, Academician Qimin Zhan, Professor Zhimin Lu and other top experts in relevant fields at home and abroad will be invited to share the latest cancer research technology and their transformation and application. This will be the area of cancer research. Another great event. The conference will consist of seven special forums on tumor and metabolic regulation; tumor transformation and precision medicine; new tumor treatment, typing and molecular markers; tumor and immunity; tumor microenvironment; tumor new technology and multi-omics metabolism research; tumor metabolism reprogramming and multi-omics research. These topics will focus on cancer metabolic reprogramming, metabolic and tumor microenvironment, and lipids. Metabolism, Metabolic Functions of Metabolic Enzymes, Metabolism and Epigenetics, Clinical Transformation, New Technologies in Cancer Immunotherapy, Clinical Applications of Cancer Immunotherapy, Emerging Targeted Therapies, PD-1 / PD-L1 Technologies, CAR-T Technologies, New tumor protein markers, novel tumor methylation markers, ctDNA, CTC, etc. At the same time, activities such as paper exchanges and selection of excellent posters will be held. We sincerely invite experts and scholars inside and outside the field, young students, and business representatives to attend this meeting.
Looking forward to October, Let’s see in Shanghai!
Shanghai First People's Hospital
China Anticancer Association Cancer Metabolism Professional Committee
Agenda
| 1st International Cancer Conference & 3rd International Conference for Cancer Metabolism and Treatment & 4th National Conference on Cancer Metabolism | |||
|---|---|---|---|
| October 13 Morning Opening Ceremony; Location：Room 205 | |||
| 08:30-09:00 | Experts | Session | Units |
| 08:30-08:40 | Speech by Xingpeng Wang, Director of Shanghai Hospital Development Center | ||
| 08:40-08:45 | Speech by Guoqiang Chen, President of Shanghai Jiao Tong University School of Medicine | ||
| 08:45-08:50 | Inauguration Ceremony of the Association of Cancer in the Yangtze River Delta | ||
| 08:50-08:55 | New journal establishment, speech by Hongyang Wang | ||
| 08:55-09:00 | Speech by Will Schweitzer, Director, American AAAS/ Science Product and Custom Publishing | ||
| 09:00-09:05 | In memory of Professor Paul Lee, speech of Vay Liang W. GO | ||
| Keynote Lecture Chairs：Guoqiang Chen, Xiaojun Peng, Erwei Song, Gang Huang | |||
| 09:05-09:25 | Qimin Zhan | TBD | Peking University |
| 09:30-09:55 | Hsing-Jien Kung | Targeting arginine-addiction and autophagy in cancers | Taipei Medical University |
| 09:55-10:20 | Dongxin Lin | TBD | Sun Yat-sen University Cancer Center |
| 10:45-11:10 | Peng Li | TBD | Tsinghua University |
| 10:20-10:45 | Erwei Song | Treat the cancer soil: turn foes into friends | Zhongshan School of Medicine, Zhongshan University |
| 11:10-11:35 | Vay Liang W. GO | The Interrelationship of pancreatic cancer with diabetes, pancreatitis, and obesity | University of California, Los Angeles |
| 11:35-12:00 | Petter Brodin | Systems-level immune monitoring in human cancer patients | Karolinska Institute, Sweden |
| 12:00-12:25 | Zhimin Lu | New research in tumor metabolism | University of Texas, USA |
| 12:00-13:30 Satellite Meeting OR Meeting The Professors | |||
| October 13 Afternoon Sub-forum（1）：Tumor and metabolic regulation; Location：Room 205 Chairs：Zhimin Lu, Jinke Cheng, Junhua Zheng, Yong Liao | |||
| 13:30-13:50 | Shimin Zhao | TBD | Fudan University |
| 13:50-14:10 | Shengcai Lin | TBD | Xiamen University |
| 14:10-14:30 | Qunying Lei | Nuclear Lactate Dehydrogenase A Senses ROS to Produce α-Hydroxybutyrate for HPV-Induced Cervical Tumor Growth | Fudan University |
| 14:30-14:50 | Qinong Ye | Six1 is a key transcription factor for the regulation of tumor glucose metabolism | Collaborative Innovation Center for CancerMedicine, Beijing |
| 14:50-15:10 | Laszlo Boros | Medicinal stable isotope chemistry through the work of Dr. Wai-Nang Paul Lee | University of California, Los Angeles |
| 15:10-15:20 | Questions | ||
| 15:20-15:40 | Weixing Zong | Cancers care about nitrogen: the other side of glutamine metabolism | Rutgers University, USA |
| 15:40-16:00 | Huafeng Zhang | Tumor cell metabolism and epigenetic regulation | University of Science and Technology of China |
| 16:00-16:20 | Guoliang Qing | Deregulation of mRNA splicing in Metabolic reprogramming and T cell leukemogenesis | Wuhan University |
| 16:20-16:40 | Chenfang Dong | Reprogamming of lipid metabolism in tumor-associated macrophage | Zhejiang University |
| 16:40-17:00 | Yuhui Jiang | The role of metabolic enzymes in the regulation of epigenetic modification in the development of pancreatic cancer | Shanghai Jiao Tong University |
| 17:00-17:20 | Questions | ||
| October 13 Afternoon Sub-forum（2）：Tumor transformation and precision medicine; Location：Room 306 Chairs：Hsing-Jien Kung, Erwei Song, Jin Li, Dingwei Ye | |||
| 13:00-13:20 | David Nanus | Genomic Uncertainties in Prostate Cancer | Cornell University School of Medicine |
| 13:20-13:40 | Jihui Hao | Accurate treatment for pancreatic cancer | Tianjin Medical University Affiliated Tumor Hospital |
| 13:40-14:00 | Jin Li | TBD | Shanghai Oriental Hospital |
| 14:00-14:20 | Mingyao Liu | G-protein coupled receptors and gene editing: from tumor microenvironment to immune cell therapy | East China Normal University |
| 14:20-14:40 | Tomoaki Kato | TBD | New York Presbyterian Hospital |
| 14:40-14:50 | Questions | ||
| 14:50-15:10 | Jie Tian | TBD | Graduate School of Chinese Academy of Sciences |
| 15:10-15:30 | Jason Wright | TBD | Columbia University |
| 15:30-15:50 | Jun Qin | Proteomic driven precision medicine | Military Medical Academy |
| 15:50-16:10 | Yongqian Shu | Progress in precision immunotherapy for gallbladder cancer | Jiangsu Province Hospital |
| 16:10-16:30 | Xuefeng Liu | Functional Patient-Derived Cell Models for Cancer Precision Medicine | Georgetown University School of Medicine |
| 16:30-16:50 | George X. Wang | Toward Precision Medicine: From Diagnosis to Target Therapy | Zhejiang Academy of Medical Sciences |
| 16:50-17:10 | Fangping Dai | Genomic characteristics Analysis of advanced tumors patients and their guiding role in clinical diagnosis and treatment | Genome Decoding of Jiangsu |
| 17:10-17:30 | Questions | ||
| October 13 Afternoon Sub-forum（3）：New tumor treatment, typing and molecular markers; Location：Room 201 Chairs：Xiangdong Wang, Jinfei Chen, Jinliang Xing, Yueyin Pan | |||
| 13:00-13:20 | Zhibin Hu | CT gene MEIOB and triple negative breast cancer | Nanjing Medical University |
| 13:20-13:40 | Huiru Tang | Reverse the TKI-Resistance of Lung Cancer by Metabolic Reprogramming | Fudan University |
| 13:40-14:00 | Ping Wang | TBD | Tongji University |
| 14:00-14:20 | Jinfei Chen | Molecular typing of gastric cancer | Nanjing Hospital Affiliated to Nanjing Medical University |
| 14:20-14:40 | Yi Yang | Tumor single-cell metabolism analysis and imaging based on molecular probe | East China University of Science and Technology |
| 14:40-14:50 | Questions | ||
| 14:50-15:10 | Lijun Di | CtBP promotes metastasis of Breast cancer through repressing Cholesterol and activating TGF-b signaling | University of Macau |
| 15:10-15:30 | Jianyu Rao | Liquid biopsy for cancer diagnosis: hype or hope | Reagan Medical Center, University of California, Los Angeles |
| 15:30-15:50 | Ahvie Herskowitz | Earliest Detection of Cancer by Circulating Tumor Cells Without Anatomic Evidence of Lesions. A Comprehensive and Integrative Approach Towards Cure | San Francisco Stem Cell Therapy Center |
| 15:50-16:10 | David Nanus | Circulating tumor cell | Cornell University School of Medicine |
| 16:10-16:30 | Wen Yi | Protein glycosylation as a key regulator of cancer metabolism and cell growth | Zhejiang University |
| 16:30-16:50 | Hai Hu | New ideas of targeting ribose metabolism for tumors treatment | Sun Yat-sen Memorial Hospital, Sun Yat-Sen University |
| 16:50-17:10 | Feng Xu | High throughput sequencing data analysis of tumor gene detection and Precision medicine | Guangdong Hybribio Biotechnology Co., Ltd. |
| 17:10-17:30 | Questions | ||
| October 14 Morning Sub-forum（4）：Tumor and immunity; Location：Room 205 Chairs： Mengtao Zhou, Zhongjun Dong, Zhiqiang Xiao, Ruian Wang | |||
| 08:30-08:50 | Zhongjun Dong | Energy metabolism regulation in anti-tumor natural immunity NK cell development and activation | Tsinghua University |
| 08:50-09:10 | Bin Li | FOXP3+ Treg functional stability in anti-tumor immune therapy | Shanghai Jiao Tong University School of Medicine |
| 09:10-09:30 | Yongsheng Li | Reprogramming of lipid metabolism in tumor-associated macrophages | Xinqiao Hospital, Third Military Medical University |
| 09:30-09:50 | Qiang Zou | Metabolic control of Treg stability and function in antitumor immunity | Shanghai Jiao Tong University School of Medicine |
| 09:50-10:10 | Taiping Zhang | Pancreatic cancer immunotherapy | Beijing Union Medical College Hospital |
| 10:10-10:20 | Questions | ||
| 10:20-10:40 | Qiang Liu | Chronic stress activates LDHA to reprogram glucose metabolism and promote stem-like traits in breast cancer | Dalian Medical University |
| 10:40-11:00 | Guang Yang | Selection and optimization of recombinant antibody targeting CXCR2 , a GPCR that involves in inflammation and cancer metastasis | Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 11:00-11:20 | Zonghai Li | CAR-T cell therapy for solid tumors | Renji Hospital, Shanghai Jiaotong University School of Medicine |
| 11:20-11:40 | Yu Cui | The Application of NGS in Immuno-therapy Research | Thermo Fisher Scientific |
| 11:40-12:00 | Questions | ||
| October 14 Morning Sub-forum（5）：Tumor microenvironment; Location：Room 306 Chairs：Jianhua Wang, Dan Xie, Qian Huang | |||
| 08:30-08:50 | Guohong Hu | The mechanism of Specific organ regulation in breast cancer metastasis | Shanghai Institutes for Biological Sciences, CAS |
| 08:50-09:10 | Fei Lan | Non-histone methyltransferase SMYD5 regulates glycolysis | Fudan University |
| 09:10-09:30 | Zhigang Zhang | Neuroendocrine regulates tumor microenvironment and metabolism | Shanghai Cancer Institute |
| 09:30-09:50 | Jianhua Wang | HIC1 deletion-mediated crosstalk between cancer cells and mammary fibroblasts promotes breast cancer progression | Fudan University Shanghai Cancer Hospital |
| 09:50-10:10 | Yong Liu | TBD | Wuhan University |
| 10:10-10:20 | Questions | ||
| 10:20-10:40 | Daming Gao | mTOR sensitizes genome to growth signal | Shanghai Institutes for Biological Sciences, CAS |
| 10:40-11:00 | Jianghua Zheng | Principle of DNA methylation and clinical implications for cancer | Fudan University |
| 11:00-11:20 | Caroline Charky | Application of 3-color Crystal Digital PCR systems in cancer: Characterizing CNV, Indels and Mutation linkage | Stilla Technologies |
| 11:20-11:40 | Questions | ||
| October 14 Morning Sub-forum（6）：Tumor new technology and metabolic multi-omics research; Location：Room 201 Chairs：Xianting Ding, Hongxia Wang, Jianqing Ding, Liqin Lu | |||
| 08:30-08:55 | Nima Aghaeepour | Multiomics Deep-profiling of the Immune System in Clinical Settings | Stanford University |
| 08:55-09:20 | Xianting Ding | Precision Medical Diagnostics and Therapeutics Based on Trace Clinical Samples | Shanghai Jiao Tong University |
| 09:20-09:45 | Bertram Bengsch | Deep immune profiling of exhausted T cells | University of Freiburg, Germany |
| 09:45-10:10 | Xiangdong Wang | Cyclic lipidomics phenotype study of clinical lung cancer | Zhongshan Hospital affiliated to Fudan University |
| 10:10-10:15 | Tea break | ||
| 10:15-10:40 | Dong Gao | Patients derived organoids and prostate cancer targeted therapy | Shanghai Institute of Biochemistry, Chinese Academy of Sciences |
| 10:40-11:05 | Zeping Hu | Research for Metabolome analysis and disease metabolism | Tsinghua University |
| 11:05-11:30 | Jinliang Xing | Mitochondrial dysfunction and tumor prevention research | The Fourth Military Medical University |
| 11:30-11:55 | Shen Hu | TBD | University of California, Los Angeles |
| 11:55-12:10 | Questions | ||
| 12:00-13:00 Meeting The Professors | |||
| October 14 Afternoon Sub-forum（7）：Tumor metabolism reprogramming and multi-omics research; Location：Room 205 Chairs：Gary Xiao, Laszlo Boros, Jun Mi, Yaogen Shu | |||
| 13:00-13:20 | Gary Guishan Xiao | Use of metabolic flux analysis to discern molecular mechanisms of OLA1-mediated drug resistance of pancreatic cancer | Dalian University of Technology |
| 13:20-13:40 | Ping Gao | CUEDC2 regulates GLUT3 and LDHA to facilitate Warbutg effects and tumorigenesis | University of Science and Technology of China |
| 13:40-14:00 | Bin Lu | N-Glycosylation Stabilizing Mer Tyrosine Kinase to Promote Hepatocellular Carcinoma Cell Proliferation and Tumor Growth via Regulating the Warburg Effect | Wenzhou Medical University |
| 14:00-14:20 | Guowang Xu | Metabolomics for the discovery of early markers in liver cancer and related mechanisms | Dalian Institute of Material Science and Technology, Chinese Academy of Sciences |
| 14:20-14:40 | Xiaojun Peng | Dye-inhibitor Conjugate: from Fluorescence Imaging to Photo-theranostics | Dalian University of Technology |
| 14:40-14:50 | Questions | ||
| 14:50-15:10 | Teresa Fan | Exploring human tumor and immune metabolism in situ & in preclinical models using Stable Isotope –Resolved Metabolomics (SIRM) | Markey Cancer Center of Kentucky University ，USA |
| 15:10-15:30 | Peng Jiang | Role of P53 in cancer cell metabolism | Tsinghua University |
| 15:30-15:50 | Weiwei Yang | Tumor metabolism reprogramming regulated by macrophages | Shanghai Institute of Biochemistry and Cell Research, Chinese Academy of Sciences |
| 15:50-16:10 | Yilun Liu | Cancer etiology of the RECQ4 disease mutations | Beckman Institute of Hope City, USA |
| 16:10-16:30 | Duojiao Wu | Metabolic reprogramming of T cell exhaustion and anti-tumor immunity | Zhongshan Hospital affiliated to Fudan University |
| 16:30-16:50 | Yue Song | Target Metabolomics and Metabolic Flow Analysis Strategies Based on High Resolution Mass Spectrometry Platform for Tumor Metabolism Research | Agilent |
| 16:50-17:10 | Questions | ||
| October 14 Afternoon Sub-forum（8）：Forum for Senoir Scientists and Young Scholars; Location：Room 201 Chairs：Gary Xiao， Bin Lu, Jianghua Zheng | |||